Layoffs alleviate Ambu's need for more capital

Ambu is cutting DKK 250m (USD 34m) from its annual costs, and this will help to ensure that the Danish medtech firm will not need to raise new capital to keep the gears turning, says CEO Britt Meelby Jensen.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Ambu downgrades, will cut costs
For subscribers
FDA clears Ambu's new bronchoscope generation
For subscribers